Continue Reading With Our 7-Day Free Trial
Unilever (NYSE: UL) did not just announce a deal—it exposed a strategy that has been building for years. That is why the market reaction was so severe. After agreeing to combine its food division with McCormick, the company’s shares sold off sharply, extending a decline that has erased roughly $42 billion in market value since its February peak. For a company long viewed as a defensive staple, that kind of move signals more than deal risk. It signals a break in investor expectations.
On the surface, this looks like a corporate restructuring. Underneath, it is a large-scale internal sector rotation.
That distinction matters.
Unilever is not merely shrinking its portfolio. It is attempting to shift investor perception—from a traditional packaged goods staple to a more premium, faster-growing beauty and personal care company with a structurally higher margin and valuation profile.
The logic is straightforward.
Beauty and wellbeing categories typically offer stronger pricing power, more resilient margins, and greater scope for premiumization than food. But the selloff suggests investors are not yet willing to underwrite that transition. The strategy may be directionally right. The path—and the timing—remain uncertain.
The Portfolio Has Been Quietly Rotating For A While
The McCormick transaction is visible, immediate, and easy to price. But the deeper story is that Unilever has already been rotating its portfolio for some time. The company reshaped roughly 15% of its portfolio in 2025 alone, completed the ice cream demerger, and continued pruning brands that no longer fit its long-term direction.
That matters because this is not a sudden pivot. It is the continuation of a multi-year capital reallocation.
What has replaced those assets is just as important.
Unilever has been acquiring into premium, digital-first, brand-led categories through deals such as Wild, Dr. Squatch, and Minimalist. These are not isolated moves. They reflect a consistent shift toward businesses where brand affinity scales online, pricing power is stronger, and performance is less tied to commodity inputs.
In effect, Unilever is moving away from a volume-driven, lower-multiple food mix toward a higher-margin, brand-led portfolio with re-rating potential.
That is what gives this story its “hidden bet” quality.
The market is focused on deal mechanics—separation complexity, leverage, tax implications, and listing structure. Those factors matter. But they are not the full picture. The more important point is that Unilever has already been reallocating capital, management focus, and strategic attention toward a different earnings mix.
In that sense, the company is not asking investors to imagine a future shift. It is asking them to recognize that the shift is already underway.
Capital Is Flowing To Beauty, Wellbeing, & Personal Care
One of the clearest signals from the earnings call was not a headline number, but capital allocation.
Unilever noted that 100% of its incremental brand and marketing investment in 2025 was directed toward Beauty & Wellbeing and Personal Care.
That is a decisive signal. Companies do not allocate capital with that level of concentration unless they believe those categories will drive the next phase of growth, margin expansion, and valuation.
The operating trends reinforce that view. Beauty & Wellbeing grew 4.3% in 2025. Personal Care grew 4.7%. Foods grew 2.5%. Core brands such as Dove and Vaseline continued to outperform, while newer wellbeing platforms like Liquid I.V. and Nutrafol delivered strong growth.
Food is not broken. Margins remain solid. But growth is slower, and the category lacks the premium, brand-led narrative that typically supports multiple expansion.
That gap—between stable cash generation and higher-growth, higher-multiple potential—is central to the strategy.
Seen through that lens, the McCormick deal is less about what Unilever is exiting and more about what it is trying to become. The company is concentrating its identity around premium positioning, digital commerce, sensorial innovation, and brand-led demand.
Those are not the characteristics of a traditional food-heavy staples business.
They are the building blocks of a higher-margin, higher-multiple consumer platform.
The market, however, is still pricing this like a complex breakup—not a potential re-rating.
The Re-Rating Case Sounds Logical, But The Bridge Looks Unstable
This is where the market’s skepticism becomes rational.
The strategy is clear. A cleaner Unilever with greater exposure to beauty, wellbeing, and personal care should, in theory, command a higher multiple than a mixed portfolio anchored in slower-growth food.
But markets do not pay for end states. They price the path. Right now, that path looks uncertain.
Investors are being asked to absorb several moving parts at once. The new food entity will be more leveraged and initially listed in New York.
That creates potential for forced selling. Some European holders may not want that exposure. Others may face index, mandate, or tax constraints. Add in the extended closing timeline, and the result is a classic unknown-asset discount.
Even investors who support the strategy may still resist the transition.
That is why the selloff looks less like a rejection of the long-term idea—and more like a lack of confidence in the execution path.
The Big Question Is Whether Unilever Can Earn A Better Identity
The final issue is not structural—it is psychological.
Even if Unilever executes this rotation successfully, what exactly will investors believe they own?
A true beauty-style compounder earns a premium because growth is durable, brand power is clear, and the category mix is structurally advantaged.
Unilever is moving in that direction, but it still carries staples expectations, staples ownership, and staples scrutiny. To its credit, management has evidence to support the shift. Gross margin reached 46.9% following the ice cream separation.
The company continues to emphasize premiumization, e-commerce expansion, and higher-growth categories. North America has already benefited from a multiyear shift toward Beauty & Wellbeing and Personal Care.
The portfolio is becoming simpler. The earnings mix is improving. Those are real building blocks.
But they do not automatically translate into a premium valuation. Beauty investors typically demand cleaner growth and less transition noise.
Staples investors prioritize stability and predictability.
For now, Unilever sits uncomfortably between those two investor bases.
Final Thoughts
The simplest way to frame Unilever today is this: the company is executing a multi-year internal sector rotation, and the market is still deciding whether that transition deserves patience—or a discount.
The strategic logic is clear. Beauty, wellbeing, and personal care offer a stronger long-term growth and margin narrative than food alone.
But the near-term frictions are equally real. Execution risk, ownership shifts, and structural complexity are still playing out.
On valuation, the reset is already visible. Based on available figures, Unilever trades at approximately 2.5x EV/Revenue, 11.7x EV/EBITDA, 12.6x EV/EBIT, and 18.2x P/E—below recent historical levels.
That leaves the stock in a middle ground. It is not fully priced for a successful re-rating.
But it is no longer valued like a stable, defensive staple either.
And that tension—between what Unilever was and what it is trying to become—is likely to define how the market prices the stock from here.
Disclaimer: We do not hold any positions in the above stock(s). Read our full disclaimer here.
